GSK (GSK) Metrics: History & Chart

GSK plc(GSK)

Drug Manufacturers - General · London, GL

$49.24-0.41 (-0.83%)

Delayed quote: Sep 25, 2026, 4:00 PM EDT

About GSK plc

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.

London, GL

66,841 employees

www.gsk.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Luke Victor Miels

View full financials

Third-Party DCF Estimate (FMP)	$121.05
Price Gap vs Third-Party Estimate	+151.50%

7D Total Return	-3.53%
30D Total Return	-3.44%
YTD Total Return	+0.75%
1Y Total Return	+20.20%
3Y Total Return	+46.17%
5Y Total Return	+48.37%
10Y Total Return	+80.95%
15Y Total Return	+147.23%
20Y Total Return	+133.89%

2026	+0.75%
2025	+51.28%
2024	-5.13%
2023	+9.72%
2022	-16.73%
2021	+27.16%
2020

CAGR TTM	+20.22%
CAGR 3Y	+13.49%
CAGR 5Y	+8.21%
CAGR 10Y	+6.11%
CAGR 15Y	+6.22%
CAGR 20Y	+4.34%

PE Ratio	15.22
PE Ratio Avg TTM	14.65
PE Ratio Avg 3Y	16.70
Current VS TTM Avg	+3.86%
Current VS 3Y Avg	-8.87%
Current VS 5Y Avg	+14.88%

All Metrics

GSK Valuation Metrics

GSK Stock Price Metrics

GSK Dividend Metrics

GSK Growth Rate Metrics

GSK Discounted Cash Flow Metrics

GSK Returns By Period

GSK Yearly Returns

GSK Average Annual Returns By Period (CAGR)

GSK Revenue Metrics

GSK PE Ratio Metrics

GSK PS Ratio Metrics

GSK PB Ratio Metrics

GSK Price to Free Cash Flow Ratio Metrics

GSK Debt to Equity Ratio Metrics

GSK PEG Ratio Metrics

GSK FCF Yield

GSK Earnings Yield

GSK EBITDA Yield

GSK OCF Yield

GSK EV/EBIT Ratio Metrics

GSK EV/EBITDA Ratio Metrics

GSK EV/Assets Ratio Metrics

GSK EV/Sales Ratio Metrics

GSK Current Ratio Metrics

GSK Quick Ratio Metrics

GSK ROIC Metrics

GSK Return on Assets Metrics

GSK Return on Equity Metrics

GSK Net Profit Margin Metrics

GSK Gross Profit Margin Metrics

GSK Tax Rate Metrics

PS Ratio	2.21
PS Ratio Avg TTM	2.37
PS Ratio Avg 3Y	2.16
Current VS TTM Avg	-6.85%
Current VS 3Y Avg	+2.19%
Current VS 5Y Avg	+4.93%

PB Ratio	4.20
PB Ratio Avg TTM	3.92
PB Ratio Avg 3Y	3.75
Current VS TTM Avg	+7.09%
Current VS 3Y Avg	+12.05%
Current VS 5Y Avg	+10.12%

PFCF Ratio	10.48
PFCF Ratio Avg TTM	12.89
PFCF Ratio Avg 3Y	13.17
Current VS TTM Avg	-18.67%
Current VS 3Y Avg	-20.44%
Current VS 5Y Avg	-13.25%

Debt/Equity Ratio	1.03
Debt/Equity Ratio Avg TTM	1.09
Debt/Equity Ratio Avg 3Y	1.21
Current VS TTM Avg	-5.27%
Current VS 3Y Avg	-14.73%
Current VS 5Y Avg	-26.80%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	9.54%
FCF Yield Avg TTM	7.78%
FCF Yield Avg 3Y	7.70%
Current VS TTM Avg	+22.61%
Current VS 3Y Avg	+23.94%
Current VS 5Y Avg	+4.89%

Earnings Yield	6.57%
Earnings Yield Avg TTM	6.72%
Earnings Yield Avg 3Y	6.34%
Current VS TTM Avg	-2.20%
Current VS 3Y Avg	+3.58%
Current VS 5Y Avg	-2.28%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	12.82
Ev/Ebit Ratio Avg TTM	12.33
Ev/Ebit Ratio Avg 3Y	14.26
Current VS TTM Avg	+4.00%
Current VS 3Y Avg	-10.07%
Current VS 5Y Avg	-10.10%

Ev/Ebitda Ratio	7.91
Ev/Ebitda Ratio Avg TTM	8.62
Ev/Ebitda Ratio Avg 3Y	9.61
Current VS TTM Avg	-8.29%
Current VS 3Y Avg	-17.72%
Current VS 5Y Avg	-17.63%

Ev/Assets Ratio	1.45
Ev/Assets Ratio Avg TTM	1.30
Ev/Assets Ratio Avg 3Y	1.13
Current VS TTM Avg	+11.47%
Current VS 3Y Avg	+27.95%
Current VS 5Y Avg	+31.43%

Ev/Sales Ratio	2.66
Ev/Sales Ratio Avg TTM	2.95
Ev/Sales Ratio Avg 3Y	2.74
Current VS TTM Avg	-9.71%
Current VS 3Y Avg	-2.99%
Current VS 5Y Avg	-3.86%

Current Ratio	0.82
Current Ratio Avg TTM	0.83
Current Ratio Avg 3Y	0.84
Current VS TTM Avg	-1.27%
Current VS 3Y Avg	-2.52%
Current VS 5Y Avg	-4.92%

Quick Ratio	0.52
Quick Ratio Avg TTM	0.54
Quick Ratio Avg 3Y	0.56
Current VS TTM Avg	-3.08%
Current VS 3Y Avg	-6.20%
Current VS 5Y Avg	-11.37%

ROIC	13.95%
ROIC Avg 3Y	10.85%
ROIC Avg 5Y	10.25%
Current VS 3Y Avg	+28.54%
Current VS 5Y Avg	+36.07%
Current VS 10Y Avg	+57.62%

ROA	7.91%
ROA Avg TTM	1.61%
ROA Avg 3Y	1.41%
Current VS TTM Avg	+390.62%
Current VS 3Y Avg	+461.06%
Current VS 5Y Avg	+442.46%

ROE	27.67%
ROE Avg TTM	25.77%
ROE Avg 3Y	24.63%
Current VS TTM Avg	+7.39%
Current VS 3Y Avg	+12.36%
Current VS 5Y Avg	+10.60%

Net Profit Margin	14.52%
Net Profit Margin Avg TTM	15.39%
Net Profit Margin Avg 3Y	13.61%
Current VS TTM Avg	-5.64%
Current VS 3Y Avg	+6.67%
Current VS 5Y Avg	-5.64%

Gross Profit Margin	72.71%
Gross Pft Margin Avg TTM	72.82%
Gross Pft Margin Avg 3Y	72.18%
Current VS TTM Avg	-0.16%
Current VS 3Y Avg	+0.73%
Current VS 5Y Avg	+1.72%

Tax Rate	(56.21%)
Tax Rate Avg 3Y	13.24%
Tax Rate Avg 5Y	11.30%
Current VS 3Y Avg	-524.43%
Current VS 5Y Avg	-597.58%
Current VS 10Y Avg	-486.57%